-Walter Ling Researcher Activity Profile

Research Author Detailed Information 

Walter Ling Publication Rate By Year

Walter Ling has published 1 paper(s) in 2003, 2 paper(s) in 2006, 5 paper(s) in 2007, for a total of 8 research publications in total.

Walter W Ling Author Information

LAST NAME: ling

FIRST NAME: walter

INITIALS: W

AFFILIATION:

Papers

Walter Ling's Publication Record

1. Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Year Published: 2003
Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, School of Medicine, University of California Los Angles, 11075 Santa Monica Boulevard, Suite 200, 90025, Los Angeles, CA, USA
2. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Year Published: 2006
Center for Health Promotion and Disease Prevention, Department of Family Medicine, David Geffen School of Medicine at UCLA, 10880 Wilshire Blvd, Suite 1800, Los Angeles, CA 90024, USA. sshoptaw@mednet.ucla.edu
3. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Year Published: 2006
Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA.
4. Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting. Year Published: 2007
University of California, Los Angeles, USA.
5. [Commentary] WHY WE DO WHAT WE DO-DELIVERY OF BUPRENORPHINE AND THE TREATMENT OF OPIOID ADDICTION. Year Published: 2007
Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd, Suite 200, Los Angeles, CA, USA.
6. Why we do what we do-delivery of buprenorphine and the treatment of opioid addiction. Year Published: 2007
Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. lwalter@ucla.edu
7. Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting. Year Published: 2007
University of California, Los Angeles, USA.
8. Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects. Year Published: 2007
Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, 30 Rolighedsvej, 1958 Frederiksberg C, Denmark. ast@life.ku.dk